New drugs approved to fight idiopathic pulmonary fibrosis

The Vanderbilt Idiopathic Pulmonary Fibrosis Center played a key role in testing the first two drugs approved by the FDA for the treatment of idiopathic pulmonary fibrosis (IPF).

Transfusions ease strokes for children with sickle cell

Vanderbilt-led research found regular blood transfusion therapy significantly reduces the recurrence of strokes in children with sickle cell anemia who have previously had “silent” strokes.

Study finds cognitive deficits common after critical illness

Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine.

Infant vaccine for pneumonia helps protect elderly

Children who receive a vaccine to prevent blood and ear infections may be reducing the spread of pneumonia to the rest of the population, especially their grandparents and other older adults.

Study finds disagreement on the role of primary care nurse practitioners

Surveillance network tracks shift in cause of childhood diarrhea

A national vaccine surveillance program that Vanderbilt University is a part of has identified a significant shift in the most common cause of childhood diarrhea.